arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Pennant Group, Inc.

PNTG
$39.70 ▲ +0.28 (+0.71%) at close
Healthcare ·Services-Health Services ·USServices-Health Services
9 Visible periods
27 Metrics
Peer-ranked Benchmarks
Price Chart
63
Health
Fair
Neutral
auto_awesome

Analytical Summary

Pennant Group, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $1.4B
Dividend Yield —
Revenue Growth 36.3% ↗
Op. Margin 5.5% →
ROIC 22.7%
FCF / Share $1.05 ↗
Trailing P/E 46.2x
Price / Book —
FCF Yield 2.6%
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 23, 2026.

9-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$947.71M
↑ +36.3% —
Net Income Profit after all expenses
$29.58M
↑ +31.1% —
Operating Margin Operating profit as % of sales
5.5%
— -0.1% 44th
FCF / Share Free cash flow per share
$1.05
↑ +8.0% —
Long-Term Debt Long-term obligations
$168.84M
— —

Health Breakdown

Profitability ↑
42
Financial Health ↑
83
Cash Quality
73

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 9 years · 33 quarters